Display options
Cite
Arnon R, Ben-Yedidia T. Preclinical efficacy of a virus-like particle-based vaccine against avian influenza H5N1. Future Microbiol. 2009;4(5):503-5doi: 10.2217/fmb.09.33.
Arnon, R., & Ben-Yedidia, T. (2009). Preclinical efficacy of a virus-like particle-based vaccine against avian influenza H5N1. Future microbiology, 4(5), 503-5. https://doi.org/10.2217/fmb.09.33
Arnon, Ruth, and Ben-Yedidia, Tamar. "Preclinical efficacy of a virus-like particle-based vaccine against avian influenza H5N1." Future microbiology vol. 4,5 (2009): 503-5. doi: https://doi.org/10.2217/fmb.09.33
Arnon R, Ben-Yedidia T. Preclinical efficacy of a virus-like particle-based vaccine against avian influenza H5N1. Future Microbiol. 2009 Jun;4(5):503-5. doi: 10.2217/fmb.09.33. PMID: 19492960.
Copy Download .nbib Format: NLM
Share it on

Future Microbiol. 2009 Jun;4(5):503-5. doi: 10.2217/fmb.09.33.

Preclinical efficacy of a virus-like particle-based vaccine against avian influenza H5N1.

Future microbiology

Ruth Arnon, Tamar Ben-Yedidia

Affiliations

  1. Department of Immunology, Weizmann Institute of Science, PO Box 26 Rehovot, 76100, Israel. [email protected]

PMID: 19492960 DOI: 10.2217/fmb.09.33

Abstract

Evaluation of: Kang S-M, Yoo D-G, Lipatov AS et al.: Induction of long-term protective immune responses by influenza H5N1 virus-like particles. PLoS ONE 4, e4667 (2009). This article describes a long-term protective effect of a vaccine candidate against avian influenza H5N1 that is based on A/Viet Nam1203/04 proteins within nonreplicating virus-like particles. The protective effect is correlated with both humoral and cellular immune responses.

Publication Types